JPRN-UMIN000005273已完成未知
The usefulness of 11C-flumazenil PET in patients with mesial temporal lobe epilepsy - The usefulness of 11C-flumazenil PET in patients with mesial temporal lobe epilepsy
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 10years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients that their epileptic foci are clealy known
研究者
相似试验
终止
2 期
The role of flumazenil infusion in the treatment of benzodiazepine withdrawalBenzodiazepine withdrawalMental Health - AddictionACTRN12616001560482Go Medical Industries Pty Ltd28
招募中
2 期
The role of flumazenil infusion in the treatment of alcohol withdrawalAlcohol withdrawal syndromeACTRN12617000039381Go Medical Industries Pty Ltd45
已完成
3 期
An open-label study of FPF1011 in patients with cerebrotendinous xanthomatosis (phase 3)Cerebrotendinous xanthomatosisJPRN-jRCT2080225062Fujimoto Pharmaceutical Corporation6
进行中（未招募）
1 期
Diagnostic value of 18F-choline PET in patients with indeterminate cytology thyroid nodule : A pilot studyPatient with a thyroid nodule =15mm with indefinite cytology according to the 2008 Bethesda classification (vesicular lesion of undetermined significancefollicular neoplasm or cell Hürthlelesion suspicious for malignancy), and to be operatedMedDRA version: 19.0 Level: HLT Classification code 10043747 Term: Thyroid neoplasms System Organ Class: 100000004860EUCTR2015-005017-71-FRCentre François Baclesse135
Unknown
2 期
Efficacy and safety of fexinidazole in patients with Human African Trypanosomiasis (HAT) due to Trypanosoma brucei rhodesiense: a multicentre, open-label clinical trialPACTR202011638938739Drugs for Neglected Diseases initiative50